Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies.

× No keyword cloud information.

18 in total

1. Alternative therapies.

Authors: P C Hoaken
Journal: CMAJ Date: 2000-03-07 Impact factor: 8.262

Review 2. How useful are unconventional cancer treatments?

Authors: E Ernst; B R Cassileth
Journal: Eur J Cancer Date: 1999-10 Impact factor: 9.162

3. Unconventional cancer therapies : what We need is rigorous research, not closed minds.

Authors: E Ernst
Journal: Chest Date: 2000-02 Impact factor: 9.410

Review 4. New insights into the physiology and pharmacology of vitamin C.

Authors: S J Padayatty; M Levine
Journal: CMAJ Date: 2001-02-06 Impact factor: 8.262

5. The philosophical basis of peer review and the suppression of innovation.

Authors: D F Horrobin
Journal: JAMA Date: 1990-03-09 Impact factor: 56.272

6. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.

Authors: E Cameron; A Campbell
Journal: Chem Biol Interact Date: 1974-10 Impact factor: 5.192

7. The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy.

Authors: E Cameron; A Campbell; T Jack
Journal: Chem Biol Interact Date: 1975-11 Impact factor: 5.192

8. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

Authors: S A Rosenberg; M T Lotze; L M Muul; S Leitman; A E Chang; S E Ettinghausen; Y L Matory; J M Skibber; E Shiloni; J T Vetto
Journal: N Engl J Med Date: 1985-12-05 Impact factor: 91.245

9. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

Authors: E T Creagan; C G Moertel; J R O'Fallon; A J Schutt; M J O'Connell; J Rubin; S Frytak
Journal: N Engl J Med Date: 1979-09-27 Impact factor: 91.245

10. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

Authors: C G Moertel; T R Fleming; E T Creagan; J Rubin; M J O'Connell; M M Ames
Journal: N Engl J Med Date: 1985-01-17 Impact factor: 91.245

5 in total

Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies.

1. Alternative therapies.

Review 2. How useful are unconventional cancer treatments?

3. Unconventional cancer therapies : what We need is rigorous research, not closed minds.

Review 4. New insights into the physiology and pharmacology of vitamin C.

5. The philosophical basis of peer review and the suppression of innovation.

6. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.

7. The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy.

8. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

9. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

10. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

1. Complementary or alternative medicine: the need for plausibility.

2. Vitamins are more Funky than Casimir thought.

3. Intravenously administered vitamin C as cancer therapy: three cases.

Review 4. Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.

5. Effectiveness of manual therapies: the UK evidence report.